» Articles » PMID: 12388633

Interactions of Human Organic Anion Transporters and Human Organic Cation Transporters with Nonsteroidal Anti-inflammatory Drugs

Overview
Specialty Pharmacology
Date 2002 Oct 22
PMID 12388633
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study was to elucidate the interactions of human organic anion transporters (hOATs) and human organic cation transporters (hOCTs) with nonsteroidal anti-inflammatory drugs (NSAIDs) using cells stably expressing hOATs and hOCTs. NSAIDs tested were acetaminophen, acetylsalicylate, salicylate, diclofenac, ibuprofen, indomethacin, ketoprofen, mefenamic acid, naproxen, piroxicam, phenacetin, and sulindac. These NSAIDs inhibited organic anion uptake mediated by hOAT1, hOAT2, hOAT3, and hOAT4. By comparing the IC(50) values of NSAIDs for hOATs, it was found that hOAT1 and hOAT3 exhibited higher affinity interactions with NSAIDs than did hOAT2 and hOAT4. HOAT1, hOAT2, hOAT3, and hOAT4 mediated the uptake of either ibuprofen, indomethacin, ketoprofen, or salicylate, but not acetylsalicylate. Although organic cation uptake mediated by hOCT1 and hOCT2 was also inhibited by some NSAIDs, hOCT1 and hOCT2 did not mediate the uptake of NSAIDs. In conclusion, hOATs and hOCTs interacted with various NSAIDs, whereas hOATs but not hOCTs mediated the transport of some of these NSAIDs. Considering the localization of hOATs, it was suggested that the interactions of hOATs with NSAIDs are associated with the pharmacokinetics and the induction of adverse reactions of NSAIDs.

Citing Articles

Contribution and expression of renal drug transporters in renal cell carcinoma.

Zuo Y, Li T, Yang S, Chen X, Tao X, Dong D Front Pharmacol. 2025; 15:1466877.

PMID: 40034145 PMC: 11873565. DOI: 10.3389/fphar.2024.1466877.


Renal organic anion transporter 1: clinical relevance and the underlying mechanisms in chronic kidney disease.

You C, Guo J, Xun Y BMC Nephrol. 2025; 26(1):93.

PMID: 39994543 PMC: 11849263. DOI: 10.1186/s12882-025-03974-y.


Application of a new MDCKII-MDR1 cell model to measure the extent of drug distribution in vitro at equilibrium for prediction of in vivo unbound brain-to-plasma drug distribution.

Langthaler K, Jones C, Saaby L, Bundgaard C, Brodin B Fluids Barriers CNS. 2024; 21(1):11.

PMID: 38273301 PMC: 10809502. DOI: 10.1186/s12987-023-00495-4.


Physiological Characterization of the Transporter-Mediated Uptake of the Reversible Male Contraceptive H2-Gamendazole Across the Blood-Testis Barrier.

Hau R, Tash J, Georg G, Wright S, Cherrington N J Pharmacol Exp Ther. 2022; 382(3):299-312.

PMID: 35779861 PMC: 9426764. DOI: 10.1124/jpet.122.001195.


The Prescription of Drugs That Inhibit Organic Anion Transporters 1 or 3 Is Associated with the Plasma Accumulation of Uremic Toxins in Kidney Transplant Recipients.

Andre C, Mernissi T, Choukroun G, Bennis Y, Kamel S, Liabeuf S Toxins (Basel). 2022; 14(1).

PMID: 35050992 PMC: 8780284. DOI: 10.3390/toxins14010015.